Company intelligence / Profile preview

Wuhan Moore Biotechnology

Ownership: Private
Development stage: Other

Overview

Wuhan Moore Biotechnology is a life sciences company based in Wuhan, China, that specializes in the research, development, and manufacturing of biological reagents. The company provides a comprehensive portfolio of products, including ELISA kits, primary and secondary antibodies, and recombinant proteins, catering to the global research community. Beyond its product offerings, Wuhan Moore Biotechnology provides professional contract research services such as customized antibody production and protein expression. Their solutions support various fields including immunology, oncology, and cell biology research. The company emphasizes quality control and technical support to ensure the reliability of its reagents in diverse experimental applications.

Modalities: AntibodyRecombinant protein
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Wuhan Moore Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan Moore Biotechnology.